NEPH Nephros, Inc. logo

NEPH Nephros, Inc.

Healthcare
$3.61+0.00%OpenMarket Cap: $39.2M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

24.78

PEG

0.02

P/B

3.45

P/S

1.97

EV/EBITDA

42.53

DCF Value

$-6.07

FCF Yield

-0.9%

Div Yield

0.0%

Margins & Returns

Gross Margin

59.1%

Operating Margin

3.5%

Net Margin

4.1%

ROE

7.7%

ROA

5.6%

ROIC

5.7%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$5.2M$140.0K$
Q4 null$4.7M$62.0K$
FY null$18.8M$1.2M$
Q3 null$4.8M$337.0K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

2 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell
Maxim GroupBuy
2025-08-08

Trading Activity

Insider Trades

View All
Krandel Judyofficer: Chief Financial Officer
SellWed Mar 25
Banks Robert R. Jr.officer: President and CEO
SellWed Mar 25
Krandel Judyofficer: Chief Financial Officer
SellWed Mar 18
Amron Arthur Hdirector
SellWed Mar 18
Spandow Oliver J.director
SellThu Nov 13

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

1.47

Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also develops and sells real-time water testing systems to provide actionable data on waterborne pathogens; and medical device products for patients with renal disease, including a 2nd generation hemodiafiltration system for the treatment of patients with end stage renal disease. In addition, it offers water filters that improve the taste and odor of water, as well as reduce biofilm, bacteria, and scale build-up in downstream equipment under the Nephros and AETHER brands for the food service, hospitality, convenience store, and health care markets. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Peers